$SLN Balance Sheet | Understand Stock

$SLN

$19.78 +$0.11 (0.56%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024
Current assets
Cash and cash equivalents
Short-term investments
R&D benefit receivable
Other current assets
Trade receivables
Total current assets
Property, plant and equipment
Operating lease right-of-use asset
Goodwill
Other intangible assets
Other long-term assets
Total assets
Current liabilities
Contract liabilities
Trade and other payables
Operating lease liabilities, current
Total current liabilities
Contract liabilities
Operating lease liabilities
Total liabilities
Shareholders' equity
Ordinary shares - par value GBP 0.05 per share; 141,739,180 shares issued at June 30, 2026 (December 31, 2025: 141,701,848)
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total shareholders' equity
Total liabilities and shareholders' equity

Comments